Bioptron Hyperlight Therapy
Bioptron Hyperlight Therapy
The wound savior Bioptron Hyperlight Therapy is a technology that provides effective and economical treatment for complex and non-healing wounds (wound care) for any part of your body. The wounds can be caused by accident, vascular disease, diabetes, high blood pressure or any other health problems.
How the Bioptron Hyperlight Therapy works?
The Hyperlight Therapy will enhance the natural regeneration process of your tissues for faster wound healing and minimal scarring. The Bioptron hyperlight therapy also reduces your pain for the whole wound healing process and the regenerated tissues are more elastic and healthy. Furthermore, the hyperlight therapy will reduce the risk of getting infections, save your cost for wound dressing as well as shorten hospitalization stay and promotes overall well being. The BIOPTRON is proven to work well for wound healing and clinically tested, certified for medical treatment.
The treatment is included
1. Wounds following trauma or surgery
3. Skin grafts
4. Venous leg ulcers (stasis ulcers)
5. Decubitus (pressure ulcers)
6. Diabetic foot ulcers
HOW BIOPTRON HYPERLIGHT TREATS WOUNDS?
BIOPTRON Hyperlight increases the mobility and migration of fibroblasts
As above mentioned the BIOPTRON Hyperlight Pro 1 can help to regenerate the tissues. This can help to increase the mobility of newly-formed fibroblasts and it’s a critical process to wound healing. BIOPTRON Hyperlight also promotes the expression of the binding factors that support this migration, contributing actively to the faster regeneration process for damaged skin. (Publication ongoing).
BIOPTRON Hyperlight increases collagen production
The Bioptron Hyperlight will increase collagen production and help your body to structure and stabilize tissues for elasticity and skin strength. BIOPTRON Hyperlight therapy fosters the recovery of tissues to a healthy and functional state (De Melo et al., 2016).
BIOPTRON Hyperlight improves microcirculation
BIOPTRON Hyperlight increases the blood flow in irradiated capillaries, boosting the oxygen and nutrients supply, as well as the uptake of nocive substances produced by damaged cells. BIOPTRON Hyperlight therapy provides to the newly-formed cells all they need to favour healthy tissue regeneration (Samoilova et al., 2008).
BIOPTRON Hyperlight promotes angiogenesis
Chronic wounds are very often characterized by poor and deficient blood supply, which could slow down and delay the recovery. BIOPTRON Hyperlight promotes angiogenesis by developing new capillaries. The increased number and length of capillaries contribute to healthy tissue regeneration and shorter recovery time (Gasparyan et al., 2005).
BIOPTRON Hyperlight decreases the risk of infections and reinforces the immune system
People might be afraid that getting infections and infections are major risk factors that affect wound management. The BIOPTRON Hyperlight contains blue light which is well known for its intrinsic antimicrobial effect without the addition of exogenous photosensitizers. The regular use of BIOPTRON Hyperlight prevents the development of bacterial infection (Opel et al, 2015). In parallel, Bioptron Hyperlight Therapy increases IL-6, which increases the production of IgM antibodies by B lymphocytes, providing defence against blood-borne pathogens (Fenyo et al., 1992). The secretion of IFN-γ is as well promoted, reinforcing the microbicidal and antiviral action of natural killer cells (Zhevago, 2006).
BIOPTRON Hyperlight diminishes inflammation
BIOPTRON Hyperlight decreases the production of proinflammatory cytokines, such as TNF-α, and increases anti-inflammatory cytokines, such as TGF –β and IL-10, in the irradiated region, reducing locally the inflammation of affected epithelium (Falus et al 2011, Zhevago 2006).
BIOPTRON Hyperlight relieves pain
Constant and intolerable pain is disabling and devastating in patients with chronic wounds. Pain impairs wound healing and slows down patient recovery. Bioptron Hyperlight Therapy reduces pain by stimulating the production of nitric oxide, which decreases the over-stimulation of somatic peripheral nerves and increases vasodilatation, diminishing in parallel the ischemic pain (Gaspariyan et al., 2005; Samoilova et al., 2008).